跳轉至內容
Merck
  • Age-related changes of hepatic clearances of cytochrome P450 probes, midazolam and R-/S-warfarin in combination with caffeine, omeprazole and metoprolol in cynomolgus monkeys using in vitro-in vivo correlation.

Age-related changes of hepatic clearances of cytochrome P450 probes, midazolam and R-/S-warfarin in combination with caffeine, omeprazole and metoprolol in cynomolgus monkeys using in vitro-in vivo correlation.

Xenobiotica; the fate of foreign compounds in biological systems (2014-11-05)
Takashi Koyanagi, Yasuharu Nakanishi, Norie Murayama, Yoshiyuki Yamaura, Kanami Ikeda, Koji Yano, Shotaro Uehara, Masahiro Utoh, Soonih Kim, Yasuhiro Uno, Hiroshi Yamazaki
摘要

1. Pharmacokinetics of human cytochrome P450 probes (caffeine, racemic warfarin, omeprazole, metoprolol and midazolam) were investigated after single intravenous and oral administrations at doses of 0.20 and 1.0 mg kg(-1), respectively, in combination to three young (3-year-old) and three aged (16-year-old) cynomolgus monkeys. 2. The plasma concentrations of caffeine and R-/S-warfarin decreased slowly in a monophasic manner, but those of omeprazole, metoprolol and midazolam decreased rapidly, in a similar manner to those as reported for pharmacokinetics in humans. 3. The mean maximum concentrations of R- and S-warfarin (4.6 and 3.7 µg/mL, respectively) in aged monkeys after oral administration were significantly higher than those in young monkeys (3.3 and 2.7 µg/mL). The mean clearance (CL) values of midazolam in aged monkeys (9.5 mL/min/kg) were significantly lower than those in young monkeys (13 mL/min/kg). 4. Individual intrinsic CL values for omeprazole (r = 0.29) and metoprolol (r = 0.30) of individual monkey livers were inversely correlated with their ages significantly (p < 0.05) in liver microsomes prepared from 55 cynomolgus monkeys. 5. These results suggest that cynomolgus monkeys could be a good model for humans, especially with particular characteristics in reduced CLs of some human P450 substrates by aging.

材料
產品編號
品牌
產品描述

Sigma-Aldrich
咖啡因, anhydrous, 99%, FCC, FG
Sigma-Aldrich
茶碱, anhydrous, ≥99%, powder
Sigma-Aldrich
咖啡因, powder, ReagentPlus®
Sigma-Aldrich
可可碱, ≥98.0%
Supelco
咖啡因, Pharmaceutical Secondary Standard; Certified Reference Material
USP
咖啡因, United States Pharmacopeia (USP) Reference Standard
USP
熔点测定用咖啡因标准品, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
奥美拉唑, solid
USP
奥美拉唑, United States Pharmacopeia (USP) Reference Standard
Supelco
咖啡因, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
奥美拉唑, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
1,7-二甲基黄嘌呤, ~98%, solid
USP
华法林, United States Pharmacopeia (USP) Reference Standard
Supelco
咖啡因, certified reference material, TraceCERT®, Manufactured by: Sigma-Aldrich Production GmbH, Switzerland
Supelco
华法林, PESTANAL®, analytical standard
Sigma-Aldrich
咖啡因, Sigma Reference Standard, vial of 250 mg
Supelco
熔点标准品 235-237°C, analytical standard
USP
茶碱, United States Pharmacopeia (USP) Reference Standard
Supelco
茶碱, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
咖啡因, anhydrous, tested according to Ph. Eur.
Supelco
Mettler-Toledo® 校准物质 ME 18872,咖啡因, traceable to primary standards (LGC)
Supelco
华法林, analytical standard
Sigma-Aldrich
咖啡因, meets USP testing specifications, anhydrous
Supelco
可可碱, analytical standard
Sigma-Aldrich
β-D-阿洛糖, rare aldohexose sugar
Sigma-Aldrich
咖啡因, BioXtra
咖啡因, European Pharmacopoeia (EP) Reference Standard
咖啡因, European Pharmacopoeia (EP) Reference Standard
茶碱, European Pharmacopoeia (EP) Reference Standard
Supelco
奥美拉唑, analytical standard